Prospective Study
Efficacy and safety of recombinant human erythropoietin (Hema-Plus®) for management of anemia in Thai patients on peritoneal dialysis
World J Nephrol
10(6):109-121.
Published online Nov 25, 2021.
doi: 10.5527/wjn.v10.i6.109
Abstract (1002)
|
Core Tip (961)
|
Article Highlights (1005)
|
Full Article (HTML) (3415)
|
Figures (1-4) (487)
|
Tables (1-6) (571)
|
Full Article (PDF)-2537K (459)
|
Audio-315K (12)
|
Peer-Review Report-204K (187)
|
Answering Reviewers-246K (182)
|
Received: 05/09/2021
|
Revised: 08/19/2021
|
Accepted: 09/17/2021
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (6)
|
Total Visits (15444)
|
Similar Articles (76)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (3)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
